12:00 AM
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

LiRIS: Phase II started

Taris began a double-blind, placebo-controlled, U.S. and Canadian Phase II trial to evaluate a single dose of 400 mg LiRIS...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >